Download | < Back |
08 Aug 2022 | |
Pursuant to Regulations 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the transcript of Analyst and Investor Conference Call for Unaudited financial results for the quarter ended June 30, 2022 conducted after the meeting of Board of Directors held on Tuesday, August 2, 2022. This is for your information and records. | |
View all announcements for Jubilant Pharmova Ltd | Source: BSE India |